跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 90,687 条关于
“Fibrostenosing Crohn's Disease”
全部
90,687
临床试验
68,047
药物
1,416
机构
172
资讯
21,052
去年
Agomab's AGMB-129 Shows Promising Results in Phase 2a Trial for Fibrostenosing Crohn's Disease
10个月前
Agomab's Ontunisertib Achieves Primary Safety Endpoint in First-in-Class Phase 2a Trial for Fibrostenosing Crohn's Disease
2个月前
Agomab Unveils Design for First-Ever Phase 2b Trial in Fibrostenosing Crohn's Disease with Oral ALK5 Inhibitor Ontunisertib
7个月前
Crohn's Disease Clinical Trials Show Promising Pipeline with Novel Therapies Advancing Through Development
去年
Antifibrotic Drug Development Gains Momentum with $3B+ in Deals and Breakthrough Clinical Results
12个月前
TGF-β Inhibitor Pipeline Expands with 25+ Companies Developing Novel Therapies for Cancer and Fibrosis
8个月前
Agomab and SpyGlass Raise Combined $350M in Biotech IPOs, Signaling Market Recovery
4年前
Risankizumab Shows Efficacy in Crohn's Disease Induction Therapy
去年
FDA Approves Lilly's Omvoh (mirikizumab) for Crohn's Disease
去年
Infliximab Maintains Efficacy in Crohn's Disease and Ulcerative Colitis Regardless of Immunosuppressant Use
第 1 页,共 2106 页
上一页
下一页